Phathom Pharmaceuticals (PHAT) Other financing activities (2019 - 2026)
Phathom Pharmaceuticals (PHAT) posted quarterly Other financing activities of $3.6 million for Q2 2026, up 4338.75% year-over-year from $80000.0 in Q2 2025, and up 500.85% quarter-over-quarter from $591000.0 in Q1 2026.
Phathom Pharmaceuticals (PHAT) Other financing activities (2019 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has reported Other financing activities for 7 consecutive years, with $3.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other financing activities rose 4338.75% year-over-year to $3.6 million; the TTM figure through Jun 2026 stood at $5.7 million (up 243.79% YoY), while the FY2025 annual figure was $1.6 million, up 2.44% from the prior year.
- Other financing activities climbed to $3.6 million in Q2 2026 per PHAT's latest filing, from $591000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $172.6 million in Q4 2023 and bottomed at $13000.0 in Q3 2023.
- Historically, Other financing activities has averaged $20.0 million across 4 years, with a median of $591000.0 in 2026.
- Annual changes were most pronounced in 2024 — Other financing activities sank 99.25% — and 2026, when it surged 4338.75%.
- Phathom Pharmaceuticals' Other financing activities stood at $172.6 million in 2023, then tumbled by 99.25% to $1.3 million in 2024, then fell by 2.39% to $1.3 million in 2025, then soared by 180.71% to $3.6 million in 2026.
- Business Quant data shows PHAT's Other financing activities at $3.6 million in Q2 2026, $591000.0 in Q1 2026, and $1.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Phathom Pharmaceuticals | 767.07 Mn | 581.73 Mn | 59.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.55 Mn |
| Jun 30, 2026 | 3.55 Mn |
| Mar 31, 2026 | 591,000.00 |
| Mar 31, 2026 | 591,000.00 |
| Dec 31, 2025 | 1.27 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 293,000.00 |
| Sep 30, 2025 | 293,000.00 |
| Jun 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 80,000.00 |
| Dec 31, 2024 | 1.30 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 282,000.00 |
| Sep 30, 2024 | 282,000.00 |
| Dec 31, 2023 | 172.55 Mn |
| Dec 31, 2023 | 172.55 Mn |
| Sep 30, 2023 | 13,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Dec 31, 2021 | 163,000.00 |
| Dec 31, 2021 | 163,000.00 |